These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5365415)

  • 1. [Medical treatment of cerebral vascular diseases in aged patients].
    Chatin B
    Therapeutique; 1969 Nov; 45(9):885-7. PubMed ID: 5365415
    [No Abstract]   [Full Text] [Related]  

  • 2. [The heparin tolerance test in the treatment of regional and diffuse atherosclerotic vascular diseases].
    Guglielmi G; Barlattani M
    Clin Ter; 1971 Aug; 58(3):229-42. PubMed ID: 5135002
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experimentation with a combination of substances having vasodilator effects on the cerebral circulation].
    Barbi G; Tallone G
    Minerva Med; 1967 Feb; 58(13):489-91. PubMed ID: 6021620
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of raubasine and dihydroergocristine on arteriosclerotic and hypertensive cerebral diseases].
    Klein K
    Vasa; 1973; 2(4):409-14. PubMed ID: 4202492
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical studies of the vasodilating activity of a new drug with adrenosympatholytic action].
    Melli A; Golinelli G
    Minerva Cardioangiol; 1967 Jun; 15(6):429-32. PubMed ID: 6056089
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients].
    Petronio G; Scali G; Casa B; Nonis E
    Clin Ter; 1980 Aug; 94(4):427-44. PubMed ID: 6257445
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
    Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
    Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of patients with cerebral and diffuse arteriosclerosis with hydergine].
    Avena G
    Hospital (Rio J); 1970 Sep; 78(3):901-28. PubMed ID: 4994595
    [No Abstract]   [Full Text] [Related]  

  • 9. [An open study on the clinical efficacy of citicoline in patients with chronic cerebral vasculopathy].
    Rossi M; Zanardi M
    Clin Ter; 1993 Feb; 142(2):141-4. PubMed ID: 8472528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of Calgam in the treatment of cerebrovascular diseases].
    Wasilewski R; Kossowska W; Rubach K
    Pol Tyg Lek; 1971 Mar; 26(9):316-8. PubMed ID: 5550673
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of epimedium compound pills in the treatment of the aged patients with kidney deficiency syndrome of ischemic cardio-cerebral vascular diseases].
    Tan X; Weng W
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(5):450-2. PubMed ID: 10682558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of an extract of ginkgo biloba (Tebonin) in the therapy of cerebral vascular diseases].
    Montanini R; Gaspari G
    Minerva Cardioangiol; 1969 Dec; 17(12):1096-102. PubMed ID: 5373481
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sturgeron treatment effectiveness in early cerebral arteriosclerosis].
    Belonog RP; Karaban' IN
    Vrach Delo; 1980 Sep; (9):67-9. PubMed ID: 7423956
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study.
    Mazighi M; Tanasescu R; Ducrocq X; Vicaut E; Bracard S; Houdart E; Woimant F
    Neurology; 2006 Apr; 66(8):1187-91. PubMed ID: 16636236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the treatment of cerebral and peripheral arterial obliterating vascular disorders with Tebonin].
    Gau HP
    Arztl Forsch; 1969; 23(3):103-11. PubMed ID: 5819754
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug therapy of cerebral arteriosclerosis in the senile age].
    Mankovsky N; Mints A
    G Gerontol; 1972 Jan; 20(1):42-9. PubMed ID: 5023587
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in coagulographic indices of patients with cerebral atherosclerosis complicated by mental disorders during the treatment process].
    Pavlova SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(7):1016-9. PubMed ID: 7415719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic cerebral circulatory insufficiency].
    Vayron de la Moureyre D
    Lille Med; 1968 Jan; 13(1):76-80. PubMed ID: 5744744
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of ribonucleic acid in cerebral atherosclerosis].
    Belonog RP; Mashek IuA
    Vrach Delo; 1974 Oct; 0(10):58-61. PubMed ID: 4417222
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of age dependent exertion insufficiency. Aspects in cerebral vascular sclerosis].
    Dittrich W
    Z Allgemeinmed; 1969 Sep; 45(27):1281-4. PubMed ID: 5386113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.